Table of Contents Table of Contents
Previous Page  504-505 / 2953 Next Page
Information
Show Menu
Previous Page 504-505 / 2953 Next Page
Page Background

…..and keeping in mind this….

„Nivolumab versus Everolimus in

advanced renal cell carcinoma“

Motzer et al., NEJM, published online a few days ago